Last reviewed · How we verify
TIDL PAIN RELIEF CRYOTHERAPY MENTHOL Cream — Competitive Intelligence Brief
marketed
Immunology
Small molecule
Live · refreshed every 30 min
Target snapshot
TIDL PAIN RELIEF CRYOTHERAPY MENTHOL Cream (CRYOTHERAPY) — Shenzhen Sam Technology Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| TIDL PAIN RELIEF CRYOTHERAPY MENTHOL Cream TARGET | CRYOTHERAPY | Shenzhen Sam Technology Co., Ltd. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- TIDL PAIN RELIEF CRYOTHERAPY MENTHOL Cream CI watch — RSS
- TIDL PAIN RELIEF CRYOTHERAPY MENTHOL Cream CI watch — Atom
- TIDL PAIN RELIEF CRYOTHERAPY MENTHOL Cream CI watch — JSON
- TIDL PAIN RELIEF CRYOTHERAPY MENTHOL Cream alone — RSS
Cite this brief
Drug Landscape (2026). TIDL PAIN RELIEF CRYOTHERAPY MENTHOL Cream — Competitive Intelligence Brief. https://druglandscape.com/ci/cryotherapy. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing